BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Prognosis
8959 results:

  • 1. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
    Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
    Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients.
    Thonusin C; Osataphan N; Leemasawat K; Nawara W; Sriwichaiin S; Supakham S; Gunaparn S; Apaijai N; Somwangprasert A; Phrommintikul A; Chattipakorn SC; Chattipakorn N
    J Transl Med; 2024 Apr; 22(1):398. PubMed ID: 38685030
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long-Noncoding-RNA HOTAIR Upregulation is Associated with Poor breast cancer Outcome: A Systematic Review and Meta Analysis.
    Suwardjo S; Gilang Permana K; Aryandono T; Heriyanto DS; Anwar SL
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1169-1182. PubMed ID: 38679975
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluation of large language models in breast cancer clinical scenarios: a comparative analysis based on ChatGPT-3.5, ChatGPT-4.0, and Claude2.
    Deng L; Wang T; Yangzhang ; Zhai Z; Tao W; Li J; Zhao Y; Luo S; Xu J
    Int J Surg; 2024 Apr; 110(4):1941-1950. PubMed ID: 38668655
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of Pregnancy on breast cancer Features and prognosis.
    Bounous VE; Minella C; Fuso L; Actis S; Petroni G; Sgrò LG; Borghese M; Tomasi Cont N; Ponzone R; Ferrero A
    Curr Oncol; 2024 Apr; 31(4):2305-2315. PubMed ID: 38668074
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling.
    Wang S; Li J; Hong S; Wang N; Xu S; Yang B; Zheng Y; Zhang J; Pan B; Hu Y; Wang Z
    J Exp Clin Cancer Res; 2024 Apr; 43(1):121. PubMed ID: 38654356
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Role of neoadjuvant rectal score in prognosis and adjuvant chemotherapy decision-making in locally advanced rectal cancer following neoadjuvant short-course radiotherapy and consolidation chemotherapy].
    Zeng Q; Tang Y; Zhou HT; Li N; Liu WY; Chen SL; Li S; Lu NN; Fang H; Wang SL; Liu YP; Song YW; Li YX; Jin J
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):335-343. PubMed ID: 38644269
    [No Abstract]    [Full Text] [Related]  

  • 8. The endonuclease FEN1 mediates activation of STAT3 and facilitates proliferation and metastasis in breast cancer.
    Wu M; Huang X; Wu B; Zhu M; Zhu Y; Yu L; Lan T; Liu J
    Mol Biol Rep; 2024 Apr; 51(1):553. PubMed ID: 38642158
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Postpartum breast cancer and Survival in Women With Germline BRCA Pathogenic Variants.
    Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
    JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathological Significance of Tumor Budding in breast Carcinoma.
    Buch A; Jain K; Rathod H; Gore C
    J Nepal Health Res Counc; 2024 Mar; 21(3):417-427. PubMed ID: 38615212
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Serum Levels of Copper and Zinc and Survival in breast cancer Patients.
    Szwiec M; Marciniak W; Derkacz R; Huzarski T; Gronwald J; Cybulski C; Dębniak T; Jakubowska A; Lener MR; Falco M; Kładny J; Baszuk P; Kotsopoulos J; Narod SA; Lubiński J
    Nutrients; 2024 Mar; 16(7):. PubMed ID: 38613033
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Soluble NKG2DLs Are Elevated in breast cancer Patients and Associate with Disease Outcome.
    Seller A; Tegeler CM; Mauermann J; Schreiber T; Hagelstein I; Liebel K; Koch A; Heitmann JS; Greiner SM; Hayn C; Dannehl D; Engler T; Hartkopf AD; Hahn M; Brucker SY; Salih HR; Märklin M
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612935
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. 3-NAntC: A Potent Crotoxin B-Derived Peptide against the Triple-Negative MDA-MB-231 breast cancer Cell Line.
    Bezerra P; Motti EF
    Molecules; 2024 Apr; 29(7):. PubMed ID: 38611925
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates.
    Bae SJ; Kook Y; Jang JS; Baek SH; Moon S; Kim JH; Lee SE; Kim MJ; Ahn SG; Jeong J
    Breast Cancer Res; 2024 Apr; 26(1):65. PubMed ID: 38609935
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Significance of Estrogen/Progesterone Receptor Expression in Metaplastic breast Carcinoma.
    Hashmi AA; Mallick BA; Rashid K; Malik UA; Zia S; Zia F; Irfan M
    Dis Markers; 2024; 2024():2540356. PubMed ID: 38601434
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics.
    Song Y; Ren S; Chen X; Li X; Chen L; Zhao S; Zhang Y; Shen X; Chen Y
    Cancer Lett; 2024 May; 590():216847. PubMed ID: 38583647
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Insights into breast cancer Knowledge Among Female Adolescents in Delta State, Nigeria: A School-Based Study.
    Akpo MO; Akpo EE; Akpo DO
    West Afr J Med; 2024 Feb; 41(2):197-201. PubMed ID: 38583066
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Discovery of an independent poor-prognosis subtype associated with tertiary lymphoid structures in breast cancer.
    Liu R; Huang X; Yang S; Du W; Chen X; Li H
    Front Immunol; 2024; 15():1364506. PubMed ID: 38571938
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study.
    Peng J; Hong Y; Chen Q; Xu F; Zhang D; Yao J; Zou Q; Yuan L; Li L; Long Q; Liao L; Liu M; Liu X; Wang S; Yi W
    Front Endocrinol (Lausanne); 2024; 15():1347762. PubMed ID: 38567311
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular features.
    Salaün H; Djerroudi L; Haik L; Schnitzler A; Bataillon G; Deniziaut G; Bièche I; Vincent-Salomon A; Debled M; Cottu P
    J Pathol Clin Res; 2024 May; 10(3):e12372. PubMed ID: 38563252
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 448.